Human CD791 knockout Raji cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
CD79A KO cell lysate available now. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control included.
View Alternative Names
B lymphocyte-specific MB1 protein, B-cell antigen receptor complex-associated protein alpha chain, CD79A antigen, CD79A_HUMAN, CD79a antigen (immunoglobulin-associated alpha), CD79a molecule, immunoglobulin-associated alpha, Ig-alpha, IgM-alpha, Immunoglobulin-associated alpha, Ly54, MB-1 membrane glycoprotein, MB1, Membrane-bound immunoglobulin-associated protein, Surface IgM-associated protein
- WB
Lab
Western blot - Human CD791 knockout Raji cell lysate (AB281361)
Lane 1 : Wild-type Raji cell lysate 20 μg
Lane 2 : CD79A knockout Raji cell lysate 20 μg
Lane 3 : Daudi cell lysate 20 μg
Lane 4 : HAP1 cell lysate 20 μg
False colour image of Western blot : Anti-CD79a antibody [EP3618] staining at 1/5000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab79414 was shown to bind specifically to CD79a. A band was observed at 40-50 kDa in wild-type Raji cell lysates with no signal observed at this size in CD79A knockout cell line ab274911 (knockout cell lysate ab281361). To generate this image, wild-type and CD79A knockout Raji cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-CD79a antibody [EP3618] (<a href='/en-us/products/primary-antibodies/cd79a-antibody-ep3618-ab79414'>ab79414</a>) at 1/5000 dilution
Lane 1:
Wild-type Raji cell lysate at 20 µg
Lane 2:
CD79A knockout Raji cell lysate at 20 µg
Lane 2:
Western blot - Human CD791 knockout Raji cell line (<a href='/en-us/products/cell-lines/human-cd791-knockout-raji-cell-line-ab274911'>ab274911</a>)
Lane 3:
Daudi cell lysate at 20 µg
Lane 4:
HAP1 cell lysate at 20 µg
Predicted band size: 25 kDa
Observed band size: 40-50 kDa
false
- WB
Lab
Western blot - Human CD791 knockout Raji cell lysate (AB281361)
All lanes:
Western blot - Anti-CD79a antibody [EPR3619] (<a href='/en-us/products/primary-antibodies/cd79a-antibody-epr3619-ab133483'>ab133483</a>) at 1/1000 dilution
Lane 1:
Wild-type Raji cell lysate at 20 µg
Lane 2:
CD79A knockout Raji cell lysate at 20 µg
Lane 3:
Daudi cell lysate at 20 µg
Secondary
Lanes 1 - 3:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 3:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 50 kDa
false
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein acts as an essential mediator in the immune system. CD79a together with CD79b forms part of the BCR complex critical for B cell development and maturation. The BCR complex activates signaling cascades that influence B cell fate decisions such as proliferation differentiation and apoptosis. By transmitting signals from the BCR CD79a helps regulate these cellular functions necessary for efficient immune defense.
Pathways
CD79a plays a pivotal role in the B cell receptor signaling pathway. This pathway involves signaling molecules such as spleen tyrosine kinase (SYK) and phosphoinositide 3-kinase (PI3K) which are activated upon BCR engagement. CD79a acts in concert with other proteins including CD79b and the IgM receptor facilitating downstream signaling cascades that ensure proper B cell responses. Its role is important for linking extracellular antigen recognition to intracellular signaling events.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Suspension
Gender
Male
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com